Join us as we begin our two part discussion of Psychedelic Assisted Psychotherapy and Integration with Dr. Arayan Sarparast of the OHSU Psilocybin Education & Assessment Collaborative for Excellence (PEACE) Clinic and clinical research coordinator Will Lucas. This episode focuses primarily on counseling patients interested in Psychedelic Assisted Psychotherapy and harm reduction strategies when working with patients that have presented to the hospital with altered mental status after ingesting Psychedelic substances. We also discuss medico-legal issues surrounding psilocybin, primarily in the state of Oregon. Stay tuned for part 2 in which we will further dive into integration and psychotherapy after psychedelic experiences.

Additional learning materials and resources for this episode can be found at:

About Oregon Psilocybin Services:⁠https://www.oregon.gov/oha/ph/preventionwellness/pages/oregon-psilocybin-services.aspx⁠

Kelan L. Thomas, B.E.S. Robert Jesse, Nicky J. Mehtani, Jennifer M. Mitchell & Brian T. Anderson (2023): Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics, Journal of Psychoactive Drugs, DOI: 10.1080/02791072.2023.2201244

Bathje GJ, Majeski E and Kudowor M (2022) Psychedelic integration: An analysis of the concept and its practice.Front. Psychol. 13:824077. doi: 10.3389/fpsyg.2022.824077

Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268-1278.

For any questions and feedback, please contact us at [email protected].

Join us for a fascinating conversation about delirium work up and management in a primarily inpatient setting with OHSU consult liaison psychiatrists Dr. Kamalika Roy and Dr. Jonathan Floriani.

Dive into an informative conversation with Developmental and Behavioral Pediatricians Dr. Randall Phelps & Dr. Amelia Roth as we discuss multimodal evaluation for Autism Spectrum Disorder in children, as well as existing supports for patients with ASD and their families and further psychiatric considerations for neurodiverse youth.

As a note, we acknowledge that ASD does not solely affect children as more and more individuals are being diagnosed at older ages, partly due to systemic injustice in the medical system. The scope of this episode is limited to workup in a pediatric population.

Hosted by Maya Singh Sharkey (she/her) and Harland Harrison (they/them)

Questions? Reach out to us at: [email protected]

Join us as psychiatrists Dr. Julie Anderson and Dr. Sean Stanley unravel the complexities of Bipolar Disorder. In the second and final part of our series on mood disorders, they discuss the diagnosis of Bipolar disorder, including the distinctions between Bipolar I and II,  as well as pharmacologic and psychosocial therapies for patients with bipolar disorder.

This discussion of Bipolar disorder is ideal for medical learners, physicians, and anyone curious about the subject. We will be discussing manic, hypomanic, and major depressive episodes in our discussion of Bipolar Disorders.

Full diagnostic criteria for those episodes can be found in Section 2 of the DSM-V under Bipolar and related disorders.

References:

1. The Sydney Bipolar Screener

2. VVA/DOD Clinical Practice Guidelines for Management of Bipolar Disorder

3. National Collaborating Centre for Mental Health (UK). Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. London: The British Psychological Society and The Royal College of Psychiatrists; 2014 Sep. PMID: 29718639. (2014, some updates 2023) 

4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170.

Tag along as psychiatrists Dr. Julie Anderson and Dr. Sean Stanley unravel the complexities of Major Depressive Disorder (MDD). In this first of two podcasts on mood disorders, they explain MDD's neurological basis, diagnosis, suicide risk assessment, and treatments ranging from medications to psychotherapy to lifestyle changes. A thoughtful discussion of MDD's multifaceted impacts ideal for medical learners, physicians, and interested minds alike.

References:

Patient Health Questionnaire (PHQ-9 & PHQ-2)

Collaborative Care Model

Columbia-Suicide Severity Rating Scale (C-SSRS)

My Resilience in Adolescence (MYRIAD) Project  

Barbui, C., Cipriani, A., & Geddes, J. R. (2008). Antidepressants and suicide symptoms: compelling new insights from the FDA’s analysis of individual patient level data. BMJ Ment Health, 11(2), 34-35.

Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. Jama, 303(1), 47-53.

Join Psychiatrists, Dr. Brandon Cornejo & Dr. Justin Laporte, for a stimulating talk about all things Transcranial Magnetic Stimulation (TMS).

Hosts: Candace Chan, MS4 & Devon Boorstein-Holler, MS4

Have Questions? Feel free to reach out to us at: [email protected]

References:

rTMS for Craving in Methamphetamine Use Disorder, a clinical trial

Carmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., ... & Zohar, J. (2019). Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. American Journal of Psychiatry, 176(11), 931-938.

Roth, Y., Tendler, A., Arikan, M. K., Vidrine, R., Kent, D., Muir, O., ... & Zangen, A. (2021). Real-world efficacy of deep TMS for obsessive-compulsive disorder: post-marketing data collected from twenty-two clinical sites. Journal of psychiatric research, 137, 667-672.

Voigt, J. D., Leuchter, A. F., & Carpenter, L. L. (2021). Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. Translational psychiatry, _11_(1), 330.

Join Neuropsychiatrist Dr. Jordan Anderson and Psychiatrist Dr. Joel Mack in an expansive discussion on the fascinating world of Functional Neurological Disorders.

Questions? [email protected]

References:

⁠https://neurosymptoms.org⁠ (Signs and symptoms of FND's including functional tremor & examples of entrainment)

Baslet, G., Seshadri, A., Bermeo-Ovalle, A., Willment, K., & Myers, L. (2016). Psychogenic non-epileptic seizures: an updated primer.⁠ _Psychosomatics_, _57_(1), 1-17

LaFrance WC Jr, Miller IW, Ryan CE, Blum AS, Solomon DA, Kelley JE, Keitner GI. Cognitive behavioral therapy for psychogenic nonepileptic seizures.⁠ Epilepsy Behav. 2009 Apr;14(4):591-6. doi: 10.1016/j.yebeh.2009.02.016. Epub 2009 Feb 20. PMID: 19233313.

Perez DL, Edwards MJ, Nielsen G, Kozlowska K, Hallett M, LaFrance WC Jr. Decade of progress in motor functional neurological disorder: continuing the momentum. J Neurol Neurosurg Psychiatry. 2021 Mar 15:jnnp-2020-323953. doi: 10.1136/jnnp-2020-323953

The Dancing Plague of 1518⁠

Dive into an enlightening conversation with Dr. David Do & Dr. James Koved as they shed light on the specialized realm of psychiatric emergency rooms, the challenges faced in modern mental health care, and the evolving landscape of emergency psychiatry.

Hosted by Candace Chan & Devon Boorstein-Holler

Questions? Reach out to us at: [email protected]

Join Psychiatrists Dr. Anne Fang, Dr. Veronica Rita Hocker, and Anaesthesiologist Dr. Natalia Guzman-Seda as they explore the electrifying clinical landscape of Electroconvulsive Therapy.

Hosted by Candace Chan & Kathleen Daily-Jensen

Questions? [email protected]

Sleep Psychiatrist Dr. John Emens takes on the topic of cognitive behavioral therapy for insomnia. 

Hosted by Allison Zhou and Nakai Corral

Questions? [email protected]

Topics covered:

Studies Mentioned:

Review of CBTI vs. medications: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481424/

Overview of the pharmacology of sleep: https://aasm.org/resources/pdf/pharmacologictreatmentofinsomnia.pdf

Study on two groups with insomnia or not, odds to develop depression: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108260/

Resource for online CBTi: https://www.sleepfoundation.org/insomnia/treatment/cognitive-behavioral-therapy-insomnia

CBTI for depression: https://academic.oup.com/sleep/article/31/4/489/2454177?login=true

IRT vs. IRT + CBT vs. Prazosin: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265653/